GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 348 filers reported holding GLOBUS MED INC in Q4 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,650,172 | -16.6% | 174,223 | 0.0% | 3.02% | -12.0% |
| Q2 2023 | $10,373,237 | +7.7% | 174,223 | +2.5% | 3.43% | +5.6% |
| Q1 2023 | $9,630,103 | -22.4% | 170,023 | +1.8% | 3.25% | -26.8% |
| Q4 2022 | $12,404,798 | +12.3% | 167,023 | -9.9% | 4.44% | +7.4% |
| Q3 2022 | $11,043,000 | -0.6% | 185,373 | -6.3% | 4.14% | +8.2% |
| Q2 2022 | $11,109,000 | -20.8% | 197,873 | +4.1% | 3.82% | -3.9% |
| Q1 2022 | $14,027,000 | +3.3% | 190,123 | +1.1% | 3.98% | +4.0% |
| Q4 2021 | $13,582,000 | -5.8% | 188,123 | 0.0% | 3.82% | -10.8% |
| Q3 2021 | $14,414,000 | -1.2% | 188,123 | 0.0% | 4.29% | +0.5% |
| Q2 2021 | $14,585,000 | +10.2% | 188,123 | -12.3% | 4.27% | -0.1% |
| Q1 2021 | $13,236,000 | -13.5% | 214,623 | -8.5% | 4.27% | -17.8% |
| Q4 2020 | $15,302,000 | +21.4% | 234,623 | -7.9% | 5.20% | +7.0% |
| Q3 2020 | $12,609,000 | +4.1% | 254,623 | +0.3% | 4.86% | -3.3% |
| Q2 2020 | $12,114,000 | +6.1% | 253,923 | -5.4% | 5.02% | -16.8% |
| Q1 2020 | $11,420,000 | -27.6% | 268,523 | +0.3% | 6.04% | -16.7% |
| Q4 2019 | $15,763,000 | +11.0% | 267,723 | -3.6% | 7.24% | -0.2% |
| Q3 2019 | $14,197,000 | +2.4% | 277,723 | -15.3% | 7.25% | +2.3% |
| Q2 2019 | $13,863,000 | +121.7% | 327,723 | +159.0% | 7.09% | +122.7% |
| Q1 2019 | $6,252,000 | +14.2% | 126,528 | 0.0% | 3.18% | -1.2% |
| Q4 2018 | $5,476,000 | -23.8% | 126,528 | 0.0% | 3.22% | -14.6% |
| Q3 2018 | $7,182,000 | +4.3% | 126,528 | -7.3% | 3.77% | -7.2% |
| Q2 2018 | $6,889,000 | -14.4% | 136,528 | -15.5% | 4.07% | -17.7% |
| Q1 2018 | $8,047,000 | +21.2% | 161,528 | 0.0% | 4.94% | +20.1% |
| Q4 2017 | $6,639,000 | +34.1% | 161,528 | -3.0% | 4.12% | +25.5% |
| Q3 2017 | $4,949,000 | -10.3% | 166,528 | 0.0% | 3.28% | -10.9% |
| Q2 2017 | $5,520,000 | +11.9% | 166,528 | 0.0% | 3.68% | +3.8% |
| Q1 2017 | $4,933,000 | +6.2% | 166,528 | -11.0% | 3.55% | -4.5% |
| Q4 2016 | $4,643,000 | – | 187,141 | – | 3.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |